Exploring the Exposome: The Next Frontier of Individualized Medicine with Konstantinos Lazaridis, M.D., Mayo Clinic

While the field of medicine has greatly benefited from genomics in recent decades, genomics alone represent only a small percentage in the cause of or contribution to human disease. The exposome — the measure of a person’s lifetime of environmental exposures and how those exposures relate to human biology in health and disease — is the next frontier in individualized medicine.

Join Konstantinos Lazaridis, M.D., executive director for Mayo Clinic’s Center for Individualized Medicine on Thursday, April 27 at Noon EDT for a presentation on the concept of the exposome, how in combination with the genome it may impact health and disease, and a major initiative to study a person’s lifetime of environmental exposures to help guide advances in disease intervention and prevention.

This event is open to all. Register in advance to attend via Zoom.

About Dr. Lazaridis

Konstantinos N. Lazaridis, M.D., is a consultant in the Division of Gastroenterology and Hepatology at Mayo Clinic and professor of medicine in the Mayo Clinic College of Medicine and Science. He serves as the Carlson and Nelson Endowed Executive Director for Mayo Clinic’s Center for Individualized Medicine.

Dr. Lazaridis has a depth of genomics expertise that comes from decades of sifting through sequences of human genomes to uncover genetic variants and mutations associated with rare liver diseases. He’s made significant contributions in genomic research and medicine in a quest to predict and better diagnose disease, as well as devise individualized treatments.

He is the principal investigator of two National Institutes of Health (NIH) funded consortia for patients afflicted with rare liver diseases, co-founder of Mayo Clinic’s Program for Rare and Undiagnosed Diseases, and co-chair of the Tapestry DNA Sequencing Research Study, a large-scalable decentralized direct to patient genomic project that has sequenced the exomes of more than 73,000 patients. Dr. Lazaridis previously served as a Mayo Foundation Scholar in Genomics in the National Human Genome Research Institute at the NIH. Learn more about his research activities in his faculty bio.